Leuthold Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Leuthold Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-27,030	Closed	-$277K	–	234
2016 Q2	$277K	Hold	27,030	–	–	0.03%	199
2016 Q1	$244K	Hold	27,030	–	–	0.03%	191
2015 Q4	$250K	Hold	27,030	–	–	0.03%	184
2015 Q3	$345K	Sell	27,030 -19,860	-42%	-$247K	0.04%	179
2015 Q2	$519K	Hold	46,890	–	–	0.05%	196
2015 Q1	$535K	Hold	46,890	–	–	0.05%	187
2014 Q4	$473K	Hold	46,890	–	–	0.05%	195
2014 Q3	$493K	Hold	46,890	–	–	0.04%	196
2014 Q2	$405K	Hold	46,890	–	–	0.03%	187
2014 Q1	$412K	Sell	46,890 -5,895	-11%	-$51.3K	0.04%	179
2013 Q4	$433K	Buy	52,785 +14,120	+37%	+$112K	0.04%	189
2013 Q3	$292K	Buy	+38,665	New	+$281K	0.03%	292

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Leuthold Group's RDY Position: Q3 2016 in Review

Leuthold Group sold out of Dr. Reddy's Laboratories (RDY) in Q3 2016, closing a stake of 27,030 shares — an estimated $277K sold.

Leuthold Group first reported a position in RDY in Q3 2013 and held it in 12 quarters. The position peaked at $535K in Q1 2015. 157 funds tracked by Wall St. Rank hold RDY as of Q3 2016.

Leuthold Group reported no remaining Dr. Reddy's Laboratories position as of Q3 2016 after selling out during the quarter.
Leuthold Group sold 27,030 Dr. Reddy's Laboratories shares in Q3 2016, an estimated $277K.
Leuthold Group first reported a position in Dr. Reddy's Laboratories in Q3 2013 and held it in 12 quarters.
Leuthold Group's Dr. Reddy's Laboratories position peaked at $535K in Q1 2015.
157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2016.

Based on Leuthold Group's 13F filing for Q3 2016, filed 14 Nov 2016.